NovoCure Limited (NVCR) Shareholders’ equity 2017–2026
NovoCure Limited (NVCR) shareholders’ equity at each fiscal year-end, per SEC filings.
$340.5MFY2026 · since FY2017: $142.3M → $340.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | $340.5M | -5.5% |
| FY2025 | $360.2M | -0.6% |
| FY2024 | $362.5M | -17.8% |
| FY2023 | $441.2M | +7.5% |
| FY2022 | $410.5M | -13.9% |
| FY2021 | $476.5M | +118.8% |
| FY2020 | $217.8M | +94.0% |
| FY2019 | $112.3M | -1.1% |
| FY2018 | $113.6M | -20.2% |
| FY2017 | $142.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice